CBSET’s partner, CILcare, will be exhibiting and presenting at the Association for Research in Otolaryngology 42nd Winter Meeting, Feb 9-13, 2019, in Baltimore, MD, USA.
CILcare will be presenting two posters:
- PS 467: “In vivo evaluation of GSK3077978A compound, a CD38 inhibitor, on age-related hearing loss in SAMP8 mice” as part of the session Inner-Ear Therapeutics I, on Sunday February 10, 2019, at 1:00 PM.
- PS 980: “Evaluation of Human and Computer-assisted Quantification of Hair Cells in Full-length Cochlea” as part of the session Inner Ear: Anatomy & Physiology, on Tuesday February 12, 2019, at 1:00 PM.
Rami Tzafriri, CBSET’s Director of Research and Development, will be attending with CILcare. CILcare will be exhibiting in Booth #8. If you would like to meet up with CBSET at the event, please contact Rami. If you would like to meet with CILcare at the event, please contact them.
Related CBSET Services:
Related CBSET & CILcare Publications:
- Intracochlear Drug Delivery Systems: A Novel Approach Whose Time Has Come. Peppi M, Marie A, Belline C, Borenstein JT. Expert Opinion in Drug Delivery. 2018 Feb 26. doi: 10.1080/17425247.2018.1444026.
by Michael Naimark, Director of Business Development, CBSET, Inc. and Marie-Pierre Pasdelou, PharmD, founder and the Chief Development Officer, CILcare
World Pharma Today: Stem Cell and Regenerative Therapies for Hearing Loss
by Michael Naimark, Director of Business Development, CBSET, Inc. and Marie-Pierre Pasdelou, PharmD, founder and the Chief Development Officer, CILcare